Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Nuvectis Pharma Inc.

    NASDAQ: NVCT · Real-Time Price · USD
    8.66
    0.25 (2.97%)
    At close: Jun 16, 2025, 3:59 PM
    8.80
    1.62%
    After-hours: Jun 16, 2025, 04:51 PM EDT

    Nuvectis Pharma Statistics

    Share Statistics

    Nuvectis Pharma has 20.89M shares outstanding. The number of shares has increased by 27.43% in one year.

    Shares Outstanding

    n/a
    		 20.89M

    Shares Change (YoY)

    n/a
    		 27.43%

    Shares Change (QoQ)

    n/a
    		 21.07%

    Owned by Institutions (%)

    n/a
    		 7.67%

    Shares Floating

    n/a
    		 10.76M

    Failed to Deliver (FTD) Shares

    n/a
    		 871

    FTD / Avg. Volume

    n/a
    		 0.64%

    Short Selling Information

    The latest short interest is 2.11M, so 10.1% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.11M

    Short % of Shares Out

    n/a
    		 10.1%

    Short % of Float

    n/a
    		 19.52%

    Short Ratio (days to cover)

    n/a
    		 17.77

    Valuation Ratios

    The PE ratio is -4.87 and the forward PE ratio is -7.89. Nuvectis Pharma's PEG ratio is 0.22.

    PE Ratio

    n/a
    		 -4.87

    Forward PE

    n/a
    		 -7.89

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.6

    PB Ratio

    n/a
    		 9.53

    P/FCF Ratio

    n/a
    		 -7.56

    PEG Ratio

    n/a
    		 0.22
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Nuvectis Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.09, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 2.09

    Quick Ratio

    n/a
    		 2.09

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,461,538.46

    Employee Count

    n/a
    		 13

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 26.42% in the last 52 weeks. The beta is -0.16, so Nuvectis Pharma's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.16

    52-Week Price Change

    n/a
    		 26.42%

    50-Day Moving Average

    n/a
    		 9.27

    200-Day Moving Average

    n/a
    		 7.37

    Relative Strength Index (RSI)

    n/a
    		 42.37

    Average Volume (20 Days)

    n/a
    		 136,677

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -19.85M

    Net Income

    n/a
    		 -19M

    EBITDA

    n/a
    		 -19M

    EBIT

    n/a
    		 -19M

    Earnings Per Share (EPS)

    n/a
    		 -1.11
    Full Income Statement

    Balance Sheet

    The company has 18.53M in cash and 0 in debt, giving a net cash position of 18.53M.

    Cash & Cash Equivalents

    n/a
    		 18.53M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -73.25M

    Total Assets

    n/a
    		 30.15M

    Working Capital

    n/a
    		 20.95M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.25M and capital expenditures 0, giving a free cash flow of -12.25M.

    Operating Cash Flow

    n/a
    		 -12.25M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -12.25M

    FCF Per Share

    n/a
    		 -0.72
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NVCT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NVCT is $17, which is 96.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $17

    Price Target Difference

    n/a
    		 96.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 7.74

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist